Johnson & Johnson 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-27 11:12 am Sale | 2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | JOHNSON & JOHNSON JNJ | 3,670,516 8.200% | -89,118 (-2.37%) | Filing |
| 2020-07-02 6:21 pm Purchase | 2020-06-30 | 13G | Fusion Pharmaceuticals Inc. FUSN | JOHNSON & JOHNSON JNJ | 3,759,634 9.000% | 3,759,634 (New Position) | Filing |